Astonea Labs Share Price Today

Astonea Labs submits rectified Q4FY25 standalone financial results to BSE

Astonea Labs submitted the missing PDF version of its Q4FY25 standalone financial results to BSE on September 22, 2026. The filing resolves discrepancies regarding missing document formats under Regulation 33 of SEBI (LODR) Regulations. FY25 revenue from operations stood at ₹9,751.83 lakh, up from ₹8,019.09 lakh in FY24. Net profit for FY25 was ₹535.05 lakh, compared to ₹407.01 lakh in the previous year. The company also resubmitted declarations under Regulation 33(3) to close pending regulatory queries.

Astonea Labs promoter Ashish Gulati buys 14,000 shares

Promoter Ashish Gulati acquired 14,000 shares of Astonea Labs Ltd. Transaction valued at ₹36,57,000 executed on Sept 15-16, 2026. Promoter stake increased from 70.81% to 70.94%. Disclosure made voluntarily under SAST Regulation 29(1).

Astonea Labs appoints internal auditor, approves $10k US investment

Chander Shekhar appointed as internal auditor for FY27. Cost audit report for FY26 taken on record without adverse remarks. $10,000 ODI approved for US subsidiary Astonea LLC. Longevity Science Private Limited approved as new subsidiary. Agreements with Astonea One Private Limited terminated immediately.

Astonea Labs re-appoints Pooja Singh as director at AGM

Astonea Labs shareholders unanimously approved all six AGM resolutions on August 21, 2026. Ms. Pooja Singh was re-appointed as a director after retiring by rotation; she heads Drug Regulatory Affairs. The company reported FY26 revenue of ₹148 crore and PAT of ₹4.51 crore. Voting participation stood at 74.58%, with promoters voting 99.93% of their holdings.

Astonea Labs seeks approval to alter MOA, invest in subsidiaries at AGM

Astonea Labs Limited has convened its 9th AGM for August 21, 2026, to approve key strategic initiatives including an amendment to its Memorandum of Association to expand pharmaceutical manufacturing and distribution channels, and authorization to invest in new Indian subsidiaries within an existing ₹100 crore limit. The meeting will also see the re-appointment of Director Pooja Singh and ratification of cost auditor remuneration.

Astonea Labs submits FY26 annual report to BSE

Astonea Labs Limited filed its FY26 Annual Report with BSE on July 24, 2026, following Board approval. The report includes audited financials, the statutory auditor's report, and the notice for the 9th AGM. The submission adheres to SEBI Regulation 34(1) requirements.